“…Homozygous or compound heterozygous CHST14 mutations have been found in 11 patients aged 0 day to 6 years at the initial publication (from four families) with ATCS [Dündar et al, 1997[Dündar et al, , 2001[Dündar et al, , 2009Janecke et al, 2001;Sonoda and Kouno, 2000], in six patients aged 2-32 years (from six families) with EDSKT [Kosho et al, 2005Miyake et al, 2010;Yasui et al, 2003], and in three patients aged 12-22 years (from two families) with MCEDS [Malfait et al, 2010]. Lack of detailed clinical information from later childhood to adulthood in ATCS and lack of detailed clinical information from birth to early childhood in EDSKT and MCEDS have made it difficult to determine whether the three conditions would be distinct clinical entities or a single clinical entity with variable expressions and with different presentations depending on the patients' ages at diagnosis , though the latter notion was suspected to be appropriate [Janecke et al, 2011;Malfait et al, 2010].…”